Methods for treating atopic dermatitis by administering an IL-4R inhibitor
US11292847B2 · kind B2 · utility
2Cited by
46References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 10, 2019 |
| Grant date | Apr 5, 2022 |
| Priority date | — |
| Expiry date | May 10, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods for treating moderate-to-severe or severe atopic dermatitis (AD). The methods of the present invention comprise administering to a subject in need thereof one or more doses of an interleukin-4 receptor (IL-4R) inhibitor such as an anti-IL-4R antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.